Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
B3GALT1 antisense RNA 1 (B3GALT1-AS1) is a long non-coding RNA (lncRNA) gene located on human chromosome 2 (genomic position chr2:167814756-167941183, hg38). It does not encode a protein but is transcribed as an RNA molecule with currently undefined functional roles. Based on available data, it is not considered a canonical therapeutic target such as a receptor, enzyme, transporter, or regulator. There are no well-established links to therapeutic targeting, drug interaction, or disease involvement, and its specific biological role is not well-characterized in the literature. No evidence suggests B3GALT1-AS1 acts as a classical therapeutic protein target. Compared to other antisense lncRNAs, B3GALT1-AS1 lacks curated functional or clinical relevance in current database or publication results.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on B3GALT1 antisense RNA 1 (B3GALT1-AS1).